Peter Borchmann
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.5%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 234
- Oncology 112
- CAR-T cell therapy research 51
- Viral-associated cancers and disorders 20
- Co-authors
- Andreas Engert (178 shared papers)Volker Diehl (86 shared papers)Michael Fuchs (120 shared papers)Bastian von Tresckow (78 shared papers)Dennis A. Eichenauer (59 shared papers)Boris Böll (40 shared papers)Hinrich P. Hansen (14 shared papers)Roland Schnell (16 shared papers)
- Journals
- Blood (91 papers)Journal of Clinical Oncology (41 papers)HemaSphere (19 papers)Annals of Oncology (15 papers)British Journal of Haematology (9 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Peter Borchmann
290 papers receiving 7.4k citations
Peter Borchmann's Hit Papers
Peers
Comparison fields: 5 of 107
- Pathology and Forensic Medicine 4.5k
- Oncology 3.0k
- Neurology 1.3k
- Genetics 920
- Immunology 1.5k
Countries citing papers authored by Peter Borchmann
This map shows the geographic impact of Peter Borchmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Borchmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Borchmann more than expected).
Fields of papers citing papers by Peter Borchmann
This network shows the impact of papers produced by Peter Borchmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Borchmann. The network helps show where Peter Borchmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Borchmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 318 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy Hit paper breakdown → | 2012 | 514 |
| 2 | 2010 | 301 | |
| 3 | 2007 | 288 | |
| 4 | 2015 | 267 | |
| 5 | 2007 | 202 | |
| 6 | 2012 | 178 | |
| 7 | 2012 | 173 | |
| 8 | 2005 | 159 | |
| 9 | 2012 | 154 | |
| 10 | 2011 | 136 | |
| 11 | 2013 | 133 | |
| 12 | 2007 | 120 | |
| 13 | 2005 | 117 | |
| 14 | A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. | 2002 | 117 |
| 15 | 2010 | 116 | |
| 16 | 2010 | 106 | |
| 17 | 2014 | 100 | |
| 18 | 2004 | 98 | |
| 19 | 2005 | 89 | |
| 20 | 2017 | 88 |
About Peter Borchmann
Peter Borchmann is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 318 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (234 papers), Lung Cancer Treatments and Mutations (79 papers), CAR-T cell therapy research (51 papers), Chronic Lymphocytic Leukemia Research (40 papers), CNS Lymphoma Diagnosis and Treatment (30 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Medical Imaging Techniques and Applications (20 papers) and Viral-associated cancers and disorders (20 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.5k citations), Oncology (3.0k citations), Neurology (1.3k citations), Genetics (920 citations) and Immunology (1.5k citations). Peter Borchmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Engert, Volker Diehl, Michael Fuchs, Bastian von Tresckow, Dennis A. Eichenauer, Boris Böll, Hinrich P. Hansen, Roland Schnell, Elke Pogge von Strandmann and Stephanie Sasse. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Annals of Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.